Pharmacokinetic & Pharmacometric Modeling

Pharmacokinetic (PK) and pharmacometric (PMX) modeling quantify how drugs move through the body-absorption, distribution, metabolism, and elimination. These models predict exposure, optimize dosing, and support preclinical-to-clinical translation. Materials Metric provides non-compartmental analysis (NCA), compartmental modeling, PK/PD modeling, and population PK (PopPK) studies using validated workflows aligned with FDA and EMA expectations.

Our analytical approach integrates experimental data, simulation tools, and statistical modeling to generate clear insights into drug transport, controlled release, degradation kinetics, and material–tissue interactions. These methods support formulation development, delivery system optimization, and model-informed decision-making across biomedical, pharmaceutical, and biomaterials applications.

Core Capabilities

Pharmacokinetic (PK) Modeling
• NCA for early exposure and clearance assessment
• One- and multi-compartment models
• Time–concentration curve modeling
• AUC, Cmax, Tmax, half-life, and clearance estimation
• PK modeling for implants, hydrogels, coatings, and controlled-release systems

Pharmacometric (PMX) & Population Modeling
• NLME/PopPK modeling to characterize variability
• Exposure–response and PK/PD relationships
• Covariate analysis (age, weight, formulation, disease state)
• Simulation of dosing strategies and regimen optimization
• Scenario testing for preclinical and translational planning

Material-Driven PK/PMX Modeling
• Drug release kinetics from polymers, scaffolds, coatings, and biomaterial surfaces
• Degradation-linked release modeling
• Transport behavior across tissues and biological interfaces
• Integration with histology, imaging, and bio-interface data

Data Integration & Model Evaluation

• Curve fitting and kinetic parameter estimation
• Bayesian or frequentist estimation workflows
• Simulation of exposure profiles
• Dose-adjustment modeling and sensitivity analysis
• Model diagnostics: goodness-of-fit, residuals, VPCs, and uncertainty analysis
• Data visualization for manuscripts, regulatory filings, and presentations

Types of Studies Supported

• Controlled-release and sustained-delivery platforms
• Polymer, hydrogel, and surface-engineered drug delivery systems
• Local vs systemic exposure prediction
• Implantable depots and transdermal or transmucosal systems
• Regenerative medicine and wound-healing therapeutics
• Bone, cartilage, and soft-tissue delivery models
• Antibiotic, growth factor, and anti-inflammatory release kinetics

Why Choose Materials Metric

Materials Metric offers quantitative modeling with deep biological and statistical insight, backed by ISO 9001:2015 quality controls.

We provide:
• FDA-aligned PK/PD modeling
• PopPK models for inter-individual variability
• Integration with toxicology and efficacy data
• Expert interpretation for regulatory filings
• Scenario simulations that accelerate decision-making

Related services

To learn more about our Pharmacokinetic & Pharmacometric Modeling service or other testing needs, please contact us.

Frequently Asked Questions

What is pharmacokinetic and pharmacometric modeling?

Pharmacokinetic (PK) and pharmacometric modeling is the mathematical description of how a compound is absorbed, distributed, metabolized, and eliminated, and how those processes relate to dose and response. Materials Metric delivers fitted models, parameter estimates, and simulations that quantify exposure and support dosing decisions. The output is a documented model with diagnostics and interpretation rather than a single number.

What does pharmacokinetic and pharmacometric modeling include?

It includes noncompartmental analysis, compartmental PK modeling, population PK with covariate analysis, and PK/PD and exposure-response modeling. We can run dose-finding simulations, estimate clearance and volume parameters, and characterize inter-individual variability. Deliverables typically cover model development, validation diagnostics, and a reporting summary suitable for internal review or regulatory context.

What data and inputs are needed for pharmacometric modeling?

We need time-concentration data, dosing records (amount, route, and schedule), and sampling times, along with relevant covariates such as body weight, age, and renal or hepatic function. For PK/PD work, matched pharmacodynamic or biomarker measurements are required. Clean, well-structured datasets with units and assay details accelerate the work, and we can advise on formatting before modeling begins.

Which methods and tools apply to pharmacometric modeling?

We use established compartmental and population modeling approaches, including nonlinear mixed-effects estimation, and standard noncompartmental methods for exposure metrics. Model selection relies on goodness-of-fit diagnostics, visual predictive checks, and bootstrap or sensitivity evaluation where appropriate. Methods follow accepted pharmacometric practice rather than a single fixed protocol, and the chosen approach is documented for each project.